Hancock Jaffe Laboratories Inc Shares float

What is the Shares float of Hancock Jaffe Laboratories Inc?

The Shares float of Hancock Jaffe Laboratories Inc is 0.000 0.00%

What is the definition of Shares float?

Shares float is the portion of shares of a corporation that are in the hands of public investors as opposed to locked-in stock.

= annual shares outstanding - closely held shares

Shares float represents the portion of shares of a corporation that are in the hands of public investors as opposed to locked-in stock held by promoters, company officers, controlling-interest investors, or government. This number is sometimes seen as a better way of calculating market capitalization because it provides a more accurate reflection of what public investors consider the company to be worth. In this context, the float may refer to all the shares outstanding that can be publicly traded

The float is calculated by subtracting the locked-in shares from outstanding shares. Stocks with smaller floats tend to be more volatile than those with larger floats. In general, the large holdings of founding shareholders, corporate cross-holdings, and government holdings in partially privatized companies are excluded when calculating the size of a public float.

Shares float of companies in the Health Care sector on NASDAQ compared to Hancock Jaffe Laboratories Inc

What does Hancock Jaffe Laboratories Inc do?

Hancock Jaffe Laboratories specializes in developing and manufacturing bioprosthetic (tissue-based) medical devices to establish improved standards of care for treating cardiac and vascular diseases. HJLI currently has two lead product candidates: the VenoValveÒ, a porcine-based valve which is intended to be surgically implanted in the deep venous system of the leg to treat reflux associated with Chronic Venous Insufficiency, and the CoreoGraftÒ, a bovine tissue-based off-the-shelf conduit intended to be used for coronary artery bypass surgery.

Companies with shares float similar to Hancock Jaffe Laboratories Inc